全球基因毒性测试市场规模、份额和成长分析：按产品和应用分类 - 产业预测（2024-2031）

Global Genetic Toxicology Testing Market Size, Share, Growth Analysis, By Product(Reagents & Consumables, Assays), By Application(Pharmaceutical & Biotechnology, Food Industry) - Industry Forecast 2024-2031

出版日期: 2024年03月08日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球基因毒性测试市场规模将为13.1亿美元，从2023年的14.8亿美元增长到2031年的38.4亿美元，并预计在预测期内（2024-2031）持续增长，预计将以复合年增长率成长2018 年为 12.70%）。

基因毒性测试在製药、生物技术和化学工业中发挥重要作用，是新药、化学物质和消费品安全评估的基本要素。此步骤确保对人类健康和环境的潜在风险进行彻底评估。由于监管力度的加强、测试技术的进步以及对公共健康和安全的日益关注，市场的重要性正在上升。推动显着增长的因素包括製药和化学领域研发活动的增加、全球卫生法规的严格化以及对接触基因毒性物质潜在长期影响的认识的提高。虽然传统测试仍然必不可少，但体外微核测定、电脑模拟和高通量筛检方法等创新技术正在对其进行补充，使其更快、更准确且更具成本效益，从而实现高品质的检查。此外，转向替代测试方法以尽量减少动物的使用符合伦理考量和监管要求，从而促进非动物测试模型的采用。市场上的主要企业，包括专门从事遗传毒性测试的委外研发机构，透过提供各种测试服务为市场的动态格局做出了贡献。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2021年）
主要市场参与者所采取的策略
关键成功策略
近期市集活动
主要企业市场占有率（2021年）

主要企业简介

Covance Inc.（USA）
Eurofins Scientific SE（Luxembourg）
Charles River Laboratories International Inc.（USA）
SGS SA（Switzerland）
Merck KGaA（Germany）
Laboratory Corporation of America Holdings（LabCorp）（USA）
Thermo Fisher Scientific Inc.（USA）
Toxikon Corporation（USA）
WuXi AppTec（China）
Genetic Toxicology Association（GTA）（USA）
BioReliance Corporation（USA）
Intertek Group plc（UK）
Shanghai Medicilon Inc.（China）
Bio-Rad Laboratories, Inc.（USA）
MPI Research（USA）
Cell Systems Corporation（USA）
CeeTox Inc.（USA）
Gentronix Ltd.（UK）
LabGenius Limited（UK）
Molecular Toxicology Inc.（USA）
Ricerca Biosciences LLC（USA）
ATCC（American Type Culture Collection）（USA）
Coy Laboratory Products Inc.（USA）
Promega Corporation（USA）
Creative Bioarray（USA）

简介目录

Product Code: SQMIG35H2189

Global Genetic Toxicology Testing Market size was valued at USD 1.31 billion in 2022 and is poised to grow from USD 1.48 billion in 2023 to USD 3.84 billion by 2031, growing at a CAGR of 12.70% during the forecast period (2024-2031).

Genetic toxicology testing plays a crucial role in the pharmaceutical, biotechnology, and chemical industries, serving as a fundamental component in the safety assessment of new drugs, chemicals, and consumer products. This phase ensures a thorough evaluation of potential risks to both human health and the environment. The market's significance is on the rise due to heightened regulatory scrutiny, advancements in testing methodologies, and an increased focus on public health and safety. Factors driving its notable growth include expanding research and development activities in pharmaceutical and chemical sectors, stringent global health regulations, and a growing awareness of the potential long-term impacts of exposure to genotoxic substances. While traditional tests remain essential, innovative techniques such as in vitro micronucleus assays, in silico modeling, and high-throughput screening methods are complementing them, facilitating faster, more accurate, and cost-effective testing. Additionally, the shift towards alternative testing methods to minimize animal usage aligns with ethical considerations and regulatory requirements, fostering the adoption of non-animal testing models. Key players in the market, including contract research organizations specializing in genetic toxicology testing, contribute to its dynamic landscape by offering a diverse range of testing services.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Genetic Toxicology Testing Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Genetic Toxicology Testing Market Segmental Analysis

The global genetic toxicology testing market is segmented on the basis of Type, Product, Application and region. By Type, the market is segmented into In Vitro, In Vivo. By Product, the market is segmented into Reagents & Consumables, Assays, Services. By Application, the market is segmented into Pharmaceutical & Biotechnology, Food Industry, Cosmetics Industry, Other. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Genetic Toxicology Testing Market

The increasing recognition among individuals and healthcare professionals regarding the significance of genetic health and its consequences serves as a major catalyst. Genetic toxicology testing plays a crucial role in pinpointing potential hazards linked to exposure to diverse environmental elements like chemicals, medications, and pollutants. This, in turn, contributes to personalized healthcare and facilitates the implementation of preventive measures.

Restraints in the Global Genetic Toxicology Testing Market

Genetic toxicology testing delves into scrutinizing an individual's genetic data, giving rise to ethical considerations regarding privacy, consent, and the potential for data misuse. The meticulous management of genetic information, encompassing its collection, storage, and utilization, necessitates adherence to stringent privacy regulations. This cautious approach may pose a challenge to the broad acceptance and integration of genetic testing practices.

Market Trends of the Global Genetic Toxicology Testing Market

The market is undergoing a notable transition towards in vitro genetic toxicology testing techniques, supplanting traditional animal-based methods with cell-based assays. This shift is fueled by the benefits these assays provide, including diminished ethical concerns, quicker results, cost-effectiveness, and enhanced relevance to human biology. In vitro approaches like the Ames test, micronucleus assay, and Comet assay are increasingly popular for their capacity to furnish precise data on the genotoxicity and mutagenicity potential of substances. Regulatory bodies are actively endorsing the adoption of in vitro methods, amplifying their incorporation into the industry.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Genetic Toxicology Testing Market by Product

Market Overview
Reagents & Consumables
Assays
Services

Global Genetic Toxicology Testing Market by Application

Market Overview
Pharmaceutical & Biotechnology
Food Industry
Cosmetics Industry
Other

Global Genetic Toxicology Testing Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Covance Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific SE (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Charles River Laboratories International Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SGS SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Laboratory Corporation of America Holdings (LabCorp) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Toxikon Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WuXi AppTec (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genetic Toxicology Association (GTA) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioReliance Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intertek Group plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shanghai Medicilon Inc. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MPI Research (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cell Systems Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CeeTox Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gentronix Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LabGenius Limited (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Molecular Toxicology Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ricerca Biosciences LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ATCC (American Type Culture Collection) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Coy Laboratory Products Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Promega Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative Bioarray (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments